News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TipRanks Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Handelsbanken Fonder AB significantly reduced its stake in Ambarella, Inc. by selling 262,293 shares, retaining 134,397 shares valued at $11.5 million. Despite this reduction, institutional investors still hold 82.09% of the company, and analysts generally maintain a "Moderate Buy" rating with a consensus price …
Estrella Immunopharma, Inc. reported a net loss of $(2.31M) for the second quarter of 2026, with a loss per share of $(0.05). The company remains pre-revenue, driven by ongoing development and corporate expenses. Key highlights include progress in clinical trials, significant milestones in a …
A shareholder of Richardson Electronics, Ltd. (RELL) has filed a Form 144 to sell up to 46,296 shares of common stock through Fidelity Brokerage Services LLC, with an aggregate value of $972,678.96. These shares originated from multiple stock awards granted as compensation between 2017 …
This article provides an overview of analyst ratings for Ambarella, Inc. (0YU1.L), including recent upgrades and downgrades from firms like B of A Securities, Susquehanna, and Rosenblatt. It lists various "Maintains" ratings, indicating that analysts reaffirmed their previous stances on the stock, mostly positive …
This article provides a comprehensive overview of Richardson Electronics, Ltd. (RELL), including its current stock price, financial performance, and company profile. It details the company's segments (Power and Microwave Technologies, Green Energy Solutions, Canvys), key financial metrics like market cap and P/E ratio, and …
Richardson Electronics (NASDAQ: RELL) will present at the 17th Annual Midwest IDEAS Investor Conference on August 26, 2026. Chairman and CEO Edward J. Richardson and COO Wendy Diddell will deliver a formal presentation and answer investor questions. The presentation will be available via webcast, …
Richardson Electronics, Ltd. (NASDAQ: RELL) announced it will present and host one-on-one meetings at the Midwest IDEAS Investor Conference on August 26, 2026, in Chicago. Chairman and CEO Edward J. Richardson and COO Wendy Diddell will deliver a formal presentation at 3:00 P.M. ET …
Ambarella, Inc. has announced its second-quarter fiscal year 2027 earnings conference call for September 3, 2026, at 1:30 p.m. Pacific Time, with the earnings release occurring after market close on the same day. Participants wishing to ask questions must complete a two-step online registration …
Ambarella SANTA CLARA, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced it will hold its second quarter fiscal year 2027 earnings conference call on Thursday, September 3, 2026 at 1:30 p.m. (Pacific Time). The …
Ambarella SANTA CLARA, Calif., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced it will hold its second quarter fiscal year 2027 earnings conference call on Thursday, September 3, 2026 at 1:30 p.m. (Pacific Time). The …
Sharemaestro market context Price below Trend Line 52 weeks -21.5% · Next-week setup negative 6.7%Estrella Immunopharma Inc. has activated a fourth clinical site, University Hospitals Cleveland Medical Center, for its STARLIGHT-1 Phase I/II trial of EB103, an investigational T-cell therapy for B-cell non-Hodgkin's lymphoma. This expansion aims to evaluate the therapy's safety and efficacy, with data expected to …
Estrella Immunopharma has announced the activation of University Hospitals Cleveland Medical Center as the fourth clinical site for its STARLIGHT-1 Phase I/II clinical trial. This trial is evaluating EB103, an ARTEMIS® T-cell therapy targeting CD19, for patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma. …
Estrella Immunopharma Inc. (NASDAQ:ESLA) has activated a fourth clinical site, University Hospitals Cleveland Medical Center, for its STARLIGHT-1 Phase I/II trial of EB103. This trial evaluates EB103, a CD19-redirected T-cell therapy, for patients with relapsed or refractory B-cell non-Hodgkin’s lymphoma. The company anticipates using …
Dimensional Fund Advisors LP reduced its stake in Richardson Electronics (NASDAQ:RELL) by 7.6% in the first quarter, now holding 715,503 shares valued at $7.84 million. Despite this, other institutional investors have increased their positions, and 71.95% of the stock is institutionally owned. The company …
Richardson Electronics (NASDAQ: RELL) recently reported strong earnings, but Simply Wall St suggests these results are of questionable quality due to a significant US$1.7 million gain from unusual items. This unusual gain, which is unlikely to be repeated, may distort the company's underlying profitability. …
The 5 Most Interesting Analyst Questions From Perella Weinberg's Q2 Earnings Call Perella Weinberg's second quarter saw flat year-over-year sales but outperformed market expectations, which was met by a significant upward move in the share price. Management attributed the result to a notable acceleration …
Andrew Bednar, CEO, Partner of New York & Director at Perella Weinberg Partners, recently sold US$4.1 million worth of company stock, reducing his holding by 26%. While another insider also sold shares in the last year, there have been no insider purchases. Insider ownership …
This article analyzes Ambarella Inc. (NASDAQ: AMBA) for tactical trading, highlighting a strong near- and mid-term sentiment but a weak long-term outlook. It identifies key price levels, support, and resistance, and outlines three AI-generated trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, tailored …
This article provides current stock information for Estrella Immunopharma Inc (ESLA), noting its recent price of $0.723 USD, a drop of 4.01%. It mentions that news and analysis, financials, stock score, technical forecast, ownership, dividends, and profile information are available, with more news expected …
Perella Weinberg Partners CEO Andrew Bednar sold approximately $4.08 million in Class A Common Stock across three transactions in early August 2026, primarily to cover tax withholding obligations on vested restricted stock units. Following these sales, Bednar directly owns over 1 million shares. This …
Richardson Electronics (NASDAQ: RELL) has expanded its Richardson Energy Storage Solutions (RESS™) portfolio with the introduction of new RESS211 and RESS422 commercial battery energy storage systems. These new systems, alongside the existing RESS760 platform, offer scalable energy storage solutions from 211kWh to 760kWh, targeting …
This SEC filing for RICHARDSON ELECTRONICS, LTD. (RELL) is a Form 144, indicating a notice of proposed sale of securities. The filing details the sale of 5,000 shares of common stock by an individual through Muriel Siebert & Co., LLC., acquired on August 20, …
State Street Corporation has filed a Schedule 13G, disclosing a passive ownership of 2,562,733 shares, or 5.8%, of Ambarella Inc. common stock. The filing indicates shared voting and dispositive power over the majority of these shares through various affiliated investment management subsidiaries, with no …
Perella Weinberg Partners CEO, Andrew Bednar, sold 235,697 shares of Class A common stock between August 5-7, 2026. The sales, totaling approximately $4.08 million, were executed solely to cover tax withholding obligations arising from vested restricted stock units. Bednar's remaining direct holdings in Class …
Wendy S. Diddell, an insider at Richardson Electronics (RELL), has filed a notice to sell up to 38,993 common shares, valued at an aggregate market value of $811,834.00, on NASDAQ around August 8, 2026. These shares originated from previous stock awards and option exercises. …
FMR LLC and Abigail P. Johnson have filed an amended Schedule 13G, reporting beneficial ownership of 9,897,190.96 shares of Perella Weinberg Partners Class A common stock, which represents 13.9% of the class. FMR LLC holds sole voting power over 9,896,595.00 shares and sole dispositive …
This article provides an earnings forecast for Estrella Immunopharma Inc (ESLA), detailing its current stock performance, market capitalization, and analyst ratings. It indicates a "Strong Buy" rating with a significant upside potential based on an updated analyst target price. The article also includes historical …
Search by ticker symbol or company name and select a result to open its chart.